Sublimbal orbital fat transposition in neurotrophic keratopathy: a case series
- Authors: Potemkin V.V.1,2, Prokopchuk V.S.1, Astakhov S.Y.1, Anikina L.K.1,2, Petukhov V.V.2, Varganova T.S.2
-
Affiliations:
- Academician I.P. Pavlov First St. Petersburg State Medical University
- City Multidisciplinary Hospital No. 2
- Issue: Vol 17, No 3 (2024)
- Pages: 69-78
- Section: Case reports
- URL: https://journals.rcsi.science/ov/article/view/266775
- DOI: https://doi.org/10.17816/OV626379
- ID: 266775
Cite item
Abstract
Neurotrophic keratopathy is a progressive condition resulting from corneal denervation, leading to the development and persistence of corneal ulcers. Among the pathogenetic treatment methods there are corneal neurotization, a technically challenging approach associated with a prolonged rehabilitation period, and the usage of recombinant human nerve growth factor (cenegermin), which is practically inaccessible due to its high cost and lack of registration in Russian Federation. We propose a technique of orbital fat transposition to the sclerocorneal pocket for the treatment of persistent ulcers associated with neurotrophic keratopathy. This method is based on neuronal embryology of orbital adipose tissue, as well as the abundance of neurotrophic factors and stem cells. This method was applied to three patients with different etiologies of neurotrophic keratopathy, reaching the observation endpoint in two months after the operation. Visual acuity was ranging from 0.005 to 0.01. All patients received standard therapy for 1–2 months without significant improvement. Surgery was then performed using the proposed technique, which involves repositioning the medial and central orbital fat pads into the sclerocorneal pocket. In the postoperative period, partial epithelialization was observed in all patients during the first week, followed by complete healing and scar formation. The maximum visual acuity in 2 months ranged from 0.06 to 0.3.
Full Text
##article.viewOnOriginalSite##About the authors
Vitaliy V. Potemkin
Academician I.P. Pavlov First St. Petersburg State Medical University; City Multidisciplinary Hospital No. 2
Email: potem@inbox.ru
ORCID iD: 0000-0001-7807-9036
SPIN-code: 3132-9163
MD, Cand. Sci. (Medicine)
Russian Federation, Saint Petersburg; Saint PetersburgVera S. Prokopchuk
Academician I.P. Pavlov First St. Petersburg State Medical University
Author for correspondence.
Email: prokopchuk.vera98@gmail.com
ORCID iD: 0000-0003-3310-6234
SPIN-code: 3654-9049
MD
Russian Federation, Saint PetersburgSergey Yu. Astakhov
Academician I.P. Pavlov First St. Petersburg State Medical University
Email: astakhov73@mail.ru
ORCID iD: 0000-0003-0777-4861
SPIN-code: 7732-1150
MD, Dr. Sci. (Medicine), Professor
Russian Federation, Saint PetersburgLiliia K. Anikina
Academician I.P. Pavlov First St. Petersburg State Medical University; City Multidisciplinary Hospital No. 2
Email: lily-sai@yandex.ru
ORCID iD: 0000-0001-8794-0457
SPIN-code: 3359-4587
Russian Federation, Saint Petersburg; Saint Petersburg
Vladimir V. Petukhov
City Multidisciplinary Hospital No. 2
Email: v.p.petukhov@gmail.com
ORCID iD: 0000-0003-4973-3937
SPIN-code: 2879-9313
MD
Russian Federation, Saint PetersburgTatiana S. Varganova
City Multidisciplinary Hospital No. 2
Email: varganova.ts@yandex.ru
ORCID iD: 0009-0000-4342-5998
MD, Cand. Sci. (Medicine)
Russian Federation, Saint PetersburgReferences
- Dua HS, Said DG, Messmer EM, et al. Neurotrophic keratopathy. Prog Retin Eye Res. 2018;66:107–131. doi: 10.1016/j.preteyeres.2018.04.003
- Kasparova EA, Marchenko NR. Neurotrophic keratitis. Etiology, pathogenesis, clinical manifestations. Review. Part 1. Ophthalmology in Russia. 2022;19(1):38–45. (In Russ.) EDN: MMMNAW doi: 10.18008/1816-5095-2022-1-38-45
- Yavuz Saricay L, Bayraktutar BN, Lilley J, et al. Efficacy of recombinant human nerve growth factor in stage 1 neurotrophic keratopathy. Ophthalmology. 2022;129(12):1448–1450. doi: 10.1016/j.ophtha.2022.08.014
- NaPier E, Camacho M, McDevitt TF, Sweeney AR. Neurotrophic keratopathy: current challenges and future prospects. Ann Med. 2022;54(1):666–673. doi: 10.1080/07853890.2022.2045035
- Roumeau S, Dutheil F, Sapin V, et al. Efficacy of treatments for neurotrophic keratopathy: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2022;260(8):2623–2637. doi: 10.1007/s00417-022-05602-z
- NaPier E, Camacho M, McDevitt TF, Sweeney AR. Neurotrophic keratopathy: current challenges and future prospects. Ann Med. 2022;54(1):666–673. doi: 10.1080/07853890.2022.2045035
- Lin KJ, Loi MX, Lien GS, et al. Topical administration of orbital fat-derived stem cells promotes corneal tissue regeneration. Stem Cell Res Ther. 2013;4(3):72. doi: 10.1186/scrt223
- Tawfik HA, Dutton JJ. Embryologic and fetal development of the human orbit. Ophthalmic Plast Reconstr Surg. 2018;34(5):405–421. doi: 10.1097/IOP.0000000000001172
- Ho JH, Ma WH, Tseng TC, et al. Isolation and characterization of multi-potent stem cells from human orbital fat tissues. Tissue Eng Part A. 2011;17(1–2):255–266. doi: 10.1089/ten.TEA.2010.0106
- Patent of the Republic of Belarus No. 14927/ 30.10.2011. Poznyak NI, Belyakovsky PV, Kovshel NM, et al. Method of surgical treatment of dystrophic diseases of the retina and optic nerve. (In Russ.) Available from: https://bypatents.com/patents/poznyak-nikolajj-ivanovich [cited 2024 April 03]
- Holan V, Palacka K, Hermankova B. Mesenchymal stem cell-based therapy for retinal degenerative diseases: experimental models and clinical trials. Cells. 2021;10(3):588. doi: 10.3390/cells10030588
- Belyakovsky PV, Poznyak NI. Neuroprotective effect of embryonic stem cells in toxic lesion of the optic nerve by kainic acid. Ophthalmology in Belarus. 2010;(3):37–42. EDN: ONNVQR (In Russ.)
- Belyakovsky PV, Poznyak NI, Poznyak SN, Kovshel NM. Therapeutic potential of mesenchymal stem cells in the treatment of degenerative changes of the posterior segment of the eye. ARS mediсa. Art of Medicine. 2012;(14):190–194. (In Russ.)
- Ezugbaia MI, Riks IA, Astakhov SYu, et al. Clinical and immunological aspects of neurotrophic keratopathy. Medline.ru. 2022;23(1):119–135. (In Russ.) EDN: SKGBMM
Supplementary files
